Tissue Factor Expression Correlates with Tumor Angiogenesis and Invasiveness in Human Hepatocellular Carcinoma

Clinical Cancer Research

Volumn 9, Issue 14, 2003, Pages 5339-5345

  Poon, Ronnie Tung Ping ^a   Lau, Cecilia Pik Yuk ^a   Ho, Joanna Wen Ying ^a   Yu, Wan Ching ^a   Fan, Sheung Tat ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; THROMBOPLASTIN; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CYTOSOL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROSPECTIVE STUDIES; THROMBOPLASTIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0242525613     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Camerer, E., Kolsto, A. B., and Prydz, H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb. Res., 81: 1-41, 1996.
2. Hillen, H. F. Thrombosis in cancer patients. Ann. Oncol., 11 (Suppl. 3): 273-276, 2000.
3. Bromberg, M. E., Konigsberg, W. H., Madison, J. F., Pawashe, A., and Garen, A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. USA, 92: 8205-8209, 1995.
4. Mueller, B. M., and Ruf, W. Requirement for binding of catalytically active factor VIIa in tissue factor dependent experimental metastasis. J. Clin. Investig., 101: 1372-1378, 1998.
5. Sawada, M., Miyake, S., Ohdama, S., Matsubara, O., Masuda, S., Yakumaru, K., and Yoshizawa, Y. Expression of tissue factor in non-small cell lung cancers and its relationship to metastasis. Br. J. Cancer, 79: 472-477, 1999.
6. Ueno, T., Toi, M., Koike, M., Nakamura, S., and Tominaga, T. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br. J. Cancer, 83: 164-170, 2000.
7. Shigemori, C., Wada, H., Matsumoto, K., Shiku, H., Nakamura, S., and Suzuki, H. Tissue factor expression and metastatic potential of colorectal cancer. Thromb. Haemost., 80: 894-898, 1998.
8. Seto, S., Onodera, H., Kaido, T., Yoshikawa, A., Ishigami, S., Arii, S., and Imamura, M. Tissue factor expression in human colorectal carcinoma. Correlation with hepatic metastasis and impact on prognosis. Cancer (Phila.), 88: 295-301, 2000.
9. Ruf, W., Fischer, E. G., Huang, H. Y., Miyagi, Y., Ott, I., Riewald, M., and Mueller, B. M. Diverse functions of protease receptor tissue factor in inflammation and metastasis. Immunol. Res., 21: 289-292, 2000.
10. Rickles, F. R., Shoji, M., and Abe, K. The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. Int. J. Hematol., 73: 145-150, 2001.
11. Koomagi, R., and Volm, M. Tissue factor expression in human non-small cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int. J. Cancer, 79: 19-22, 1998.
12. Abdulkadir, S. A., Carvalhal, G. F., Kaleem, Z., Kisiel, W., Humphrey, P. A., Catalona, W. J., and Milbrandt, J. Tissue factor expression and angiogenesis in human prostate carcinoma. Hum. Pathol., 31: 443-447, 2000.
13. Nakasaki, T., Wada, H., Shigemori, C., Miki, C., Gabazza, E. C., Nobori, T., Nakamura, S., and Shiku, H. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am. J. Hematol., 69: 247-254, 2002.
14. Shoji, M., Hancock, W. W., Abe, K., Micko, C., Casper, K. A., Baine, R. M., Wilcox, J. N., Danave, I., Dillehay, D. L., Matthews, E., Contrino, J., Morrissey, J. H., Gordon, S., Edgington, T. S., Kudryk, B., Kreutzer, D. L., and Rickles, F. R. Activation of coagulation and angiogenesis in cancer. Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am. J. Pathol., 152: 399-411, 1998.
15. Abe, K., Shoji, M., Chen, J., Bierhaus, A., Danave, I., Micko, C., Casper, K., Dillehay, D. L., Nawroth, P. P., and Rickles, F. R. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc. Natl. Acad. Sci. USA, 96: 8663-8668, 1999.
16. Tanigawa, N., Lu, C., Mitsui, T., and Miura, S. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology, 26: 1216-1223, 1997.
17. Poon, R. T., Ng, I. O., Lau, C., Zhu, L. X., Yu, W. C., Lo, C. M., Fan, S. T., and Wong, J. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann. Surg., 233: 227-235, 2001.
18. Sugimachi, K., Tanaka, S., Terashi, T., Taguchi, K., Rikimaru, T., and Sugimachi, K. The mechanisms of angiogenesis in hepatocellular carcinoma: angiogenic switch during tumor progression. Surgery (St. Louis), 131 (Suppl. 1): S135-S141, 2002.
19. Poon, R. T., Ng, I. O., Lau, C., Yu, W. C., Yang, Z. F., Fan, S. T., and Wong, J. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J. Clin. Oncol., 20: 1775-1785, 2002.
20. Eppenberger, U., Kueng, W., Schlaeppi, J. M., Roesel, J. L., Benz, C., Mueller, H., Matter, A., Zuber, M., Luescher, K., Litschgi, M., Schmitt, M., Foekens, J. A., and Eppenberger-Castori, S. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J. Clin. Oncol., 16: 3129-3136, 1998.
21. Linderholm, B., Grankvist, K., Wilking, N., Johansson, M., Tavelin, B., and Henriksson, R. Correlation of VEGF content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. J. Clin. Oncol., 18: 1423-1431, 2000.
22. Edmonson, H. A., and Steiner, P. E. Primary carcinoma of the liver: a study of 100 among 489,000 necropsies. Cancer (Phila.), 7: 462-503, 1954.
23. Sobin, L. H., and Wittekind, C. (eds.). TNM classification of malignant tumors, Ed. 5. New York: Wiley-Liss, 1997.
24. Poon, R. T., Fan, S. T., and Wong, J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann. Surg., 232: 10-24, 2000.
25. Yoshiji, H., Kuriyama, S., Yoshii, J., Yamazaki, M., Kikukawa, M., Tsujinoue, H., Nakatani, T., and Fukui, H. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells. Hepatology, 28: 1489-1496, 1998.
26. Li, X. M., Tang, Z. Y., Zhou, G., Lui, Y. K., and Ye, S. L. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma. J. Exp. Clin. Cancer Res., 17: 13-17, 1998.
27. Park, Y. N., Kim, Y. B., Yang, K. M., and Park, C. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch. Pathol. Lab. Med., 124: 1061-1065, 2000.
28. Browder, T., Folkman, J., and Pirie-Shepherd, S. The hemostatic system as a regulator of angiogenesis. J. Biol. Chem., 275: 1521-1524, 2000.
29. Nash, G. F., Walsh, D. C., and Kakkar, A. K. The role of the coagulation system in tumour angiogenesis. Lancet Oncol., 2: 608-613, 2001.
30. Saaristo, A., Karpanen, T. K., and Alitalo, K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene, 19: 6122-6129, 2000.
31. Okada, S., Shimada, K., Yamamoto, J., Takayama, T., Kosuge, T., Yamasaki, S., Sakamoto, M., and Hirohashi, S. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology, 106: 1618-1624, 1994.
32. El-Assal, O. N., Yamanoi. A., Soda, Y., Yamaguchi, M., Yu, L., and Nagasue, N. Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma. Surgery (St. Louis), 122: 571-577, 1997.
33. Poon, R. T., Fan, S. T., Lo, C. M., Liu, C. L., and Wong, J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann. Surg., 229: 216-222, 1999.
34. Lauwers, G. Y., and Vauthey, J. N. Pathological aspects of hepatocellular carcinoma: a critical review of prognostic factors. Hepatogastroenterology, 45: 1197-1202, 1998.
35. Kakkar, A. K., Lemoine, N. R., Scully, M. F., Tebbutt, S., and Williamson, R. C. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br. J. Surg., 82: 1101-1104, 1995.
36. Hamada, K., Kuratsu, J., Saitoh, Y., Takeshima, H., Nishi, T., and Ushio, Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer (Phila.), 77: 1877-1883, 1996.
37. Poon, R. T., Fan, S. T., and Wong, J. Clinical implications of circulating angiogenic factors in cancer patients. J. Clin. Oncol., 19: 1207-1225, 2001.
38. Poon, R. T., Lau, C. P., Cheung, S. T., Yu, W. C., and Fan, S. T. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Cancer Res., 63: 3121-3126, 2003.
39. Folkman, J., Browder, T., and Palmbald, J. Angiogenesis research: guidelines for translation to clinical application. Thromb. Haemost., 86: 23-33, 2001.
40. Befeler, A. S., and Di Bisceglie, A. M. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology, 122: 1609-1619, 2002.
41. Kang, M. A., Kim, K. Y., Seol, J. Y., Kim, K. C., and Nam, M. J. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor. J. Gene Med., 2: 289-296, 2000.
42. Francis, J. L., and Amirkhosravi, A. Effect of antihemostatic agents on experimental tumor dissemination. Semin. Thromb. Haemost., 28: 29-38, 2002.
43. Amirkhosravi, A., Meyer, T., Chang, J. Y., Amaya, M., Siddiqui, F., Desai, H., and Francis, J. L. Tissue factor pathway inhibitor reduces experimental lung metastasis of B 16 melanoma. Thromb. Haemost., 87: 930-936, 2002.
44. Amirkhosravi, A., Meyer, T., Warnes, G., Amaya, M., Malik, Z., Biggerstaff, J. P., Siddiqui, F. A., Sherman, P., and Francis, J. L. Pentoxifylline inhibits hypoxia-induced up-regulation of tumor cell tissue factor and vascular endothelial growth factor. Thromb. Haemost., 80: 598-602, 1998.
45. Saito, T., Koyama, T., Nagata, K., Kamiyama, R., and Hirosawa, S. Andcoagulant effect of retinoic acid on leukemia cells. Blood, 87: 657-665, 1996.